President & CEOOfficers of the CorporationBoard of TrusteesFoundation BoardLeadership CouncilAbout Joslin ResearchAdvocacy & Gov't AffairsHistory
Newly DiagnosedManaging DiabetesChildhood DiabetesNutritionExerciseOnline Diabetes ClassesDiscussion BoardsJoslin Clinical ResearchInfo for Healthcare ProfessionalsJoslin Clinical Guidelines
Make an AppointmentAdult ClinicYoung Adult Transition CarePediatricsEye CareWeight Management ProgramsDO ITMental Health & CounselingReferring PhysiciansBillingAfrican American ProgramsAsian ClinicLatino Diabetes InitiativeAbout Joslin ResearchVolunteer for Clinical Research StudiesInfo for Healthcare ProfessionalsClinical Guidelines
Directory of Joslin InvestigatorsDiabetes Research Center Alumni ConnectionVolunteer for Clinical Research Studies
Media RelationsNews ReleasesInside Joslin
Affiliated CentersPharma & DeviceCorporate EducationPublicationsProfessional EducationInternationalCause MarketingHealthcare ProfessionalsCommercialization and VenturesJoslin Institute for Technology Translation (JITT)
Give NowHigh Hopes FundWays to GivePlanned GivingEventsGet InvolvedCorporate & Foundation SupportOur DonorsDevelopment Team

Board of Trustees

Solid leadership is critical to the success of a world-class institution like Joslin. 

Joslin's Board of Trustees is made up of local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of a future without diabetes.

Joslin's Board of Trustees works closely with the Joslin executive staff. Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge — the hallmark of this one-of-a-kind Center.

Ralph James, Chairperson of the Joslin Board of Trustees is Executive Director of External Relations at Harvard Business School, responsible for development and alumni relations activities for HBS.
[more]

Peter S. Amenta, MD, PhD is Dean of UMDNJ-Robert Wood Johnson Medical School. He has been a member of the UMDNJ-Robert Wood Johnson Medical School (RWJMS) faculty since 1989, and served as Residency Program Director and Chief of the Pathology Service at Robert Wood Johnson University Hospital, as well as Senior Vice President of Medical Affairs and Chief of Staff.  [more]

Michael Astrue is the former Commissioner of Social Security (2007-2013). The Social Security Administration is an independent federal agency headquartered in suburban Baltimore with over 62,000 employees nationwide.  As commissioner, Astrue reported directly to President Obama. [more]

John Cook, Counsel, Seaward Management. John joined Seaward in March 1999 and was a Managing Director through 2013. John joined Seaward in March 1999 and was a Managing Director through 2013.   [more]

Nathaniel Gardiner is the co-chair of the Life Sciences Group at Edwards Wildman Palmer LLP. He serves as General Counsel to public and private life sciences and technology companies in a wide range of corporate matters, including public and private equity offerings and acquisitions, plus a variety of other business arrangements and strategic and corporate governance matters. [more]

James Geraghty is Entrepreneur-in-Residence at Third Rock Ventures. Having helped Genzyme launch rare disease therapies around the world, James assists the firm in creating companies focused on rare genetic diseases and supports existing portfolio companies in related spaces. [more]

Morella Mendoza de Grossmann has served for over 20 years on the Board of the important Venezuelan Food Division of Empresas Polar, and serves on the Board of Productos EFE, the leading ice cream company in Venezuela [more]

Roberta Herman M.D. was, until July 2013, was the Chief Operating Officer for Harvard Pilgrim Health Care, one of New England’s largest non-profit managed health care organizations, providing care and coverage to over one million members throughout Massachusetts, Maine, and New Hampshire. [more]

Jessica Hopfield, Ph.D. is a former partner of McKinsey & Company in their Global Pharmaceutical practice. While at McKinsey from 1995-2009, Ms. Hopfield served clients across pharmaceutical, biotech, medical device and consumer industries with a focus on strategy formulation, R&D management and marketing. [more]

Ann Lagasse was a founder of Piper Properties Management, Inc., a real estate development and management company in Newburyport, MA. Since the 1980’s, she and her husband, Chuck, have been instrumental in the revitalization and restoration of the Newburyport historic downtown and waterfront. [more]

James Petersen is President of JLP Consulting, LLC, located in Geneva, Switzerland. From 2003 to 2005, he was an advisor to Warburg Pincus LLC, a private equity group. In 1980, he joined Haemonetics as Director of European Operations and served in various roles until 1998 when he was appointed President and CEO.[more]

Geoffrey Rehnert is the Co-Chief Executive Officer of Audax Group, a leading middle market private equity firm founded in 1999.  Audax manages in excess of $ 5.0 billion in equity and debt capital. Under Geoff’s leadership, the firm has invested in more than 300 portfolio companies. [more]

Mark E. Russell is vice president of Engineering, Technology and Mission Assurance for Raytheon Company. He assumed the position in July 2008, and was elected a company officer in June 2008.  [more]

Richard Smith is the Co-Chairman of the Richard and Susan Smith Family Foundation. Dick has held a wide range of influential business and civic positions over the course of his career. He was the former Chairman of the Board and CEO of Harcourt General, the Neiman Marcus Group and the GC Companies. He has held directorships at the First National Bank of Boston, Liberty Mutual Insurance Company and Wang Laboratories. [more]

Ex Officio


John L. Brooks, III, President and CEO, Joslin Diabetes Center, a well-known life sciences executive, was appointed President and Chief Executive Officer in March 2011, having previously served as Chairman of the Joslin Board of Trustees. [more]

Robert A. Gabbay, M.D., Ph.D., FACP, Chief Medical Officer, has over 35 years of clinical and research experience and is Chief Medical Officer and Senior Vice President at Joslin Diabetes Center. [more]

Dr. King M.D. is the Director of Research and Head of the Section on Vascular Cell Biology at Joslin, as well as a Professor of Medicine at Harvard Medical School. [more]

Honorary Trustees


Charles Hood is the President of Charles H. Hood Foundation. His grandfather founded H.P.Hood & Sons and his father was the former CEO and President. During his tenure on the Joslin Board, he served as Vice Chair, an Incorporator, Treasurer and on various Trustee committees. [more]

Patrick O'Neill has served as senior executive for numerous mining companies located throughout the world. In 1982, he became an independent mining consultant until his retirement in 2005. Patrick has served on numerous civic and professional organizations. During his tenure at Joslin, he served as Board Chair and Chair of the Committee overseeing the construction of the Howard F. Root wing of Joslin. [more]

Ken Quickel, M.D. is President Emeritus of the Joslin Diabetes Center. He served as CEO from 1987-2000 and again from 2008-2010. He was a staff physician at Beth Israel Deaconess Medical Center, a lecturer at Harvard Medical School, a trustee of both Beth Israel Deaconess Medical Center and CareGroup and an Overseer of Brigham & Women’s Hospital. [more]

Page last updated: September 21, 2014